Amelioration of delayed-type hypersensitivity responses by IL-27 administration

Yoshiyuki Miyazaki, Yohei Shimanoe, Seng Wang, Hiroki Yoshida

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Interleukin (IL-) 27 is a member of the IL-12 cytokine family. Although recent analyses of WSX-1 (IL-27 receptor α chain)-deficient mice as well as in vitro studies using recombinant IL-27 revealed the immunosuppressive function of IL-27, in vivo role and therapeutic potential of IL-27 remain poorly elucidated. Here we investigated the effect of IL-27 administration on delayed-type hypersensitivity (DTH). While WSX-1-deficient mice showed higher DTH responses as shown by the degree of footpad swelling, administration of IL-27 significantly ameliorated the footpad swelling. Since the activation status of the draining lymph node cells were not affected by IL-27 deficiency, it was suggested that IL-27 affected the effector phase of the response. These results collectively indicate that IL-27 has a suppressive effect on activated T cells in the experimental model and also has a therapeutic potential for some diseases caused by immune disorder.

Original languageEnglish
Pages (from-to)397-402
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume373
Issue number3
DOIs
Publication statusPublished - Aug 29 2008
Externally publishedYes

Fingerprint

Interleukin-27
Delayed Hypersensitivity
Swelling
T-cells
Interleukins
Interleukin-12
Immunosuppressive Agents
Immune System Diseases

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Amelioration of delayed-type hypersensitivity responses by IL-27 administration. / Miyazaki, Yoshiyuki; Shimanoe, Yohei; Wang, Seng; Yoshida, Hiroki.

In: Biochemical and Biophysical Research Communications, Vol. 373, No. 3, 29.08.2008, p. 397-402.

Research output: Contribution to journalArticle

@article{43bb407570e34cbb9a8cbfc0c47b1d28,
title = "Amelioration of delayed-type hypersensitivity responses by IL-27 administration",
abstract = "Interleukin (IL-) 27 is a member of the IL-12 cytokine family. Although recent analyses of WSX-1 (IL-27 receptor α chain)-deficient mice as well as in vitro studies using recombinant IL-27 revealed the immunosuppressive function of IL-27, in vivo role and therapeutic potential of IL-27 remain poorly elucidated. Here we investigated the effect of IL-27 administration on delayed-type hypersensitivity (DTH). While WSX-1-deficient mice showed higher DTH responses as shown by the degree of footpad swelling, administration of IL-27 significantly ameliorated the footpad swelling. Since the activation status of the draining lymph node cells were not affected by IL-27 deficiency, it was suggested that IL-27 affected the effector phase of the response. These results collectively indicate that IL-27 has a suppressive effect on activated T cells in the experimental model and also has a therapeutic potential for some diseases caused by immune disorder.",
author = "Yoshiyuki Miyazaki and Yohei Shimanoe and Seng Wang and Hiroki Yoshida",
year = "2008",
month = "8",
day = "29",
doi = "10.1016/j.bbrc.2008.06.038",
language = "English",
volume = "373",
pages = "397--402",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Amelioration of delayed-type hypersensitivity responses by IL-27 administration

AU - Miyazaki, Yoshiyuki

AU - Shimanoe, Yohei

AU - Wang, Seng

AU - Yoshida, Hiroki

PY - 2008/8/29

Y1 - 2008/8/29

N2 - Interleukin (IL-) 27 is a member of the IL-12 cytokine family. Although recent analyses of WSX-1 (IL-27 receptor α chain)-deficient mice as well as in vitro studies using recombinant IL-27 revealed the immunosuppressive function of IL-27, in vivo role and therapeutic potential of IL-27 remain poorly elucidated. Here we investigated the effect of IL-27 administration on delayed-type hypersensitivity (DTH). While WSX-1-deficient mice showed higher DTH responses as shown by the degree of footpad swelling, administration of IL-27 significantly ameliorated the footpad swelling. Since the activation status of the draining lymph node cells were not affected by IL-27 deficiency, it was suggested that IL-27 affected the effector phase of the response. These results collectively indicate that IL-27 has a suppressive effect on activated T cells in the experimental model and also has a therapeutic potential for some diseases caused by immune disorder.

AB - Interleukin (IL-) 27 is a member of the IL-12 cytokine family. Although recent analyses of WSX-1 (IL-27 receptor α chain)-deficient mice as well as in vitro studies using recombinant IL-27 revealed the immunosuppressive function of IL-27, in vivo role and therapeutic potential of IL-27 remain poorly elucidated. Here we investigated the effect of IL-27 administration on delayed-type hypersensitivity (DTH). While WSX-1-deficient mice showed higher DTH responses as shown by the degree of footpad swelling, administration of IL-27 significantly ameliorated the footpad swelling. Since the activation status of the draining lymph node cells were not affected by IL-27 deficiency, it was suggested that IL-27 affected the effector phase of the response. These results collectively indicate that IL-27 has a suppressive effect on activated T cells in the experimental model and also has a therapeutic potential for some diseases caused by immune disorder.

UR - http://www.scopus.com/inward/record.url?scp=47249144061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249144061&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2008.06.038

DO - 10.1016/j.bbrc.2008.06.038

M3 - Article

C2 - 18572017

AN - SCOPUS:47249144061

VL - 373

SP - 397

EP - 402

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -